Febuxostat Sandoz 80 mg film-coat. tabl.

Negara: Belgia

Bahasa: Inggris

Sumber: AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

Beli Sekarang

Bahan aktif:

Febuxostat Hemihydrate 82,28 mg - Eq. Febuxostat 80 mg

Tersedia dari:

Sandoz SA-NV

Kode ATC:

M04AA03

INN (Nama Internasional):

Febuxostat Hemihydrate

Dosis:

80 mg

Bentuk farmasi:

Film-coated tablet

Komposisi:

Febuxostat Hemihydrate 82.28 mg

Rute administrasi :

Oral use

Area terapi:

Febuxostat

Ringkasan produk:

CTI code: 514960-06 - Pack size: 98 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 514960-07 - Pack size: 30 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 514960-02 - Pack size: 28 - Commercialisation status: NO - FMD code: 07613421019990 - CNK code: 3906575 - Delivery mode: Medical prescription; CTI code: 514986-05 - Pack size: 84 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 514960-03 - Pack size: 42 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 514986-04 - Pack size: 56 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 514960-04 - Pack size: 56 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 514986-03 - Pack size: 42 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 514960-05 - Pack size: 84 - Commercialisation status: YES - FMD code: 07613421019983 - CNK code: 3906567 - Delivery mode: Medical prescription; CTI code: 514986-02 - Pack size: 28 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 514986-07 - Pack size: 30 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 514960-01 - Pack size: 14 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 514986-06 - Pack size: 98 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 514986-01 - Pack size: 14 - Commercialisation status: NO - Delivery mode: Medical prescription

Status otorisasi:

Commercialised: No

Tanggal Otorisasi:

2017-08-24

Dokumen dalam bahasa lain

Selebaran informasi Selebaran informasi Jerman 08-03-2024
Selebaran informasi Selebaran informasi Prancis 08-03-2024
Karakteristik produk Karakteristik produk Prancis 08-03-2024
RMP RMP Prancis 10-11-2022
DHPC DHPC Prancis 14-12-2022
Selebaran informasi Selebaran informasi Belanda 08-03-2024
Karakteristik produk Karakteristik produk Belanda 08-03-2024
RMP RMP Belanda 10-11-2022
DHPC DHPC Belanda 14-12-2022